Professional Documents
Culture Documents
SymSitive 1609 - PB
SymSitive 1609 - PB
SymSitive 1609 - PB
1609
4-t-Butylcyclohexanol
INSTANT
SKIN RELIEF
SOOTHING
Symrise – Cosmetic Ingredients – Consumer & Market Insights – CICS 2021 – 5 countries
SYMRISE INNOVATION
TARGETING SPECIFIC
DISCOMFORT
SENSATIONS
SymSitive® 1609
ULTIMATE SKIN TOLERANCE SOLUTION
INCREASES
SKIN COMFORT
BENEFITS
CLINICALLY PROVEN TO
REDUCE BURNING &
STINGING SENSATIONS
70%
ASSETS
NATURAL ORIGIN
CONTENT
(ISO 16128)
99.9% PATENTED
READILY BIODEGRADABLE
SymSitive® 1609
FOR AN INSTANT SKIN & SCALP RELIEF
APPLICATIONS
MAIN APPLICATIONS
with pH between 3 and 12
PROTOCOL
3 30 VOLUNTEERS SENSITIVE TO
CAPSAICIN. NASOLABIAL FOLD
APPLICATION.
2 -70% DAY 1: ASSESSMENT SAMPLE WITH
**** SymSitive® 1609 VS CONTROL. DAY
-60% 2: ASSESSMENT SAMPLE WITHOUT
1 *** -67% SymSitive® 1609 VS CONTROL.
-50% *** EVALUATION OF STINGING,
* BURNING, TINGLING & TIGHTNESS
0 EFFECT 3MIN AFTER APPLICATION.
STINGING BURNING TINGLING TIGHTNESS
22 VOLUNTEERS SENSITIVE TO
RETINOL. 1 NASOLABIAL FOLD
2 APPLICATION OF EMULSION
FORMULA WITH 1% RETINOL VS
PLACEBO AND 1% RETINOL + 3%
SymSitive® 1609 VS PLACEBO.
1 - 76% - 83%
- 72% ***
EVALUATION OF DISCOMFORT
** ** (STINGING, ITCHING, WARMING
- 72% SENSATIONS) AT 30S, 2.5MIN, 5MIN
AND 10MIN AFTER APPLICATION.
0
T30 sec T2.5 min T5 min T10 min
IN VIVO STUDY
1.2% of SymSitive® 1609 significantly helps to down-modulate overall
misperceptions by 65% as fast as 1min and immediately reduces facial
misperceptions felt by persons with CIS.
D1+1mn Baseline+3m
Baseline+1m D1+3mn D5+1mn
Day 5+1m D5+3mn
Day 5+3m
0,2
Variation of discomfort sensations
PROTOCOL
20 VOLUNTEERS SUFFERING FROM
-0,3 CIS. 2x DAILY APPLICATION ON
HALF FACE VS PLACEB FOR 5
DAYS. TESTED PRODUCT: O/W
EMULSION WITH & WIHOUT 1.2%
-0,8 - 65% SymSitive® 1609.
* ASSESSMENT OF OVERALL
MISPERCEPTIONS (INCLUDING
-1,3 - 25% STINGING & BURNING) AFTER 1
- 20% AND 3 MINUTES AFTER NOXIOUS
SENSORY STIMULATION.
-1,8
IN VIVO STUDY
SymSitive® 1609 eases discomfort sensations of scalp sensitive to hair coloration
without changing the expected shade of coloration.
Discomfort on PROTOCOL
15 VOLUNTEERS WITH SENSITIVE
both hemi-heads SCALP TO HAIR COLORATION,
13% WITH OILY OR DRY HAIR.
SINGLE & STANDARDIZED HEMI-
Reduced HEAD APPLICATION OF
discomfort on 13% PROFESSIONAL SOFT HAIR
treated hemi-head COLORATION FOR SENSITIVE
SCAKP (WITHOUT AMMONIAC
13% 61% WITH MEA) + 3% SymSitive® 1609
No functional No functional MIXED TO THE HAIR COLORATION
discomfort on discomfort on JUST BEFORE APPLICATION VS
both hemi-head treated hemi-head PLACEBO (COLORATION).
ASSESSMENT OF PRODUCT
TOLERANCE & INFLUENCE ON THE
SHADE OF COLORATION BY
% OF SUBJECTS VOLUNTEERS & HAIRDRESER.
ACTIVES SOOTHING SKIN TOLERANCE
SymSitive® 1609
INCI: Pentylene Glycol, 4-t-Butylcyclohexanol
Product number
399944
Formulation details
Colorless to pale yellow clear & odorless liquid
Recommended dose: 1.0 - 3.0%
Soluble in glycols, common cosmetic oils and alcohol
Stable and effective over a wide pH (3-12) and up to 85°C
Compatible with widely used cosmetic ingredients
Main applications
Suitable for sensitive skin care, lotions & serums, hair colors, perms & relaxers, oral care
DISCLAIMER
“These suggestions and data are based on information we believe to be reliable. They are offered in good faith, but without guarantee, as conditions and
methods of use of our products are beyond our control. Symrise makes no warranties, either expressed or implied, as to the accuracy or appropriateness of
this data. Symrise expressly disclaims any implied warranty of fitness for a particular use. We recommend that prospective users determine for themselves
the suitability of Symrise materials and suggestions for any use prior to their adoption. We also recommend that prospective users, as required, obtain
approval from appropriate regulatory authorities. Suggestions for uses of our products or the inclusion of descriptive material from patents and the citation
of specific patents in this publication should not be understood as recommending the use of our products in violation of any patent or as a permission or
licence to use any patent of Symrise.”